Top Markets
Coin of the day
Oryzon Genomics S.A. Oryzon Genomics S.A.

Oryzon Genomics S.A.

ORY
Κατάταξη σε μετοχές #16859
Oryzon Genomics S.A., a clinical stage biopharmaceutical company, engages in... Oryzon Genomics S.A., a clinical stage biopharmaceutical company, engages in the discovery and development of epigenetics-based therapeutics for patients with cancer and CNS (central nervous system), oncology, and hematology disorders. Its clinical phase compounds include iadademstat (ORY-1001), a selective LSD1 inhibitor that is in Phase II trials for oncology; and vafidemstat (ORY-2001), a CNS-optimized LSD1 inhibitor, which is in Phase II trials for the treatment of CNS and psychiatric diseases. Its product candidates also comprise ORY-3001, an LSD1 inhibitor that is in preclinical development for the treatment of non-oncological diseases; and ORY-4001, a selective HDAC-6 inhibitor for the treatment of neurological disorders, such as Charcot-Marie-Tooth disease (CMT), amyotrophic lateral sclerosis (ALS), and others. It also has collaborations in precision medicine with Columbia University in New York and the Institute of Medical and Molecular Genetics (INGEMM) at La Paz Hospital in Madrid psychometrically characterize patients with mutations in the SetD1A or Shank3 genes; and Cooperative Research and Development Agreement (CRADA) to sponsor several clinical trials. The company was incorporated in 2000 and is based in Cornellà de Llobregat, Spain.
Τιμή μετοχής
$3.32
Κεφαλαιοποίηση
$272.01M
Αλλαγή (1 ημέρα)
0.21%
Αλλαγή (1 έτος)
8.43%
Χώρα
ES
Εμπόριο Oryzon Genomics S.A. (ORY)

Κατηγορία

Ιστορικό τιμής μετοχής για την Oryzon Genomics S.A. (ORY)
Υψηλότερη τιμή κλεισίματος: $3.32 στις 2026-09-01

Χαμηλότερη τιμή κλεισίματος: $4.05 στις 2015-12-01
Ιστορικό τιμής μετοχής της Oryzon Genomics S.A. από 2015 έως 2026
Ετήσια απόδοση τιμής μετοχής
Έτος Απόδοση
2026 (TTM) -3.02%
2025 127.05%
2024 -28.98%
2023 -7.72%
2022 -20.86%
2021 -17.47%
2020 14.60%
2019 14.88%
2018 -16.03%
2017 -30.04%
2016 21.22%
2015 0.00%
Τιμή μετοχής για παρόμοιες εταιρείες ή ανταγωνιστές
Εταιρεία Τιμή μετοχής Μεταβολή 1Έτ% Χώρα
$548.15 36.70%
US
$1.03K 45.33%
NL
$153.87 536.09%
US
$122.21 -10.03%
AU
$756.67 8.05%
CH